ALC:NYSE
Alcon AG
74,13Â $
arrow_upward
+0,64%(+0,47) 1 p
17. nov, 12:34:25 GMT −5 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ALC põhistatistika genereerimine…
Ava
73,40Â $
Kõrge
74,26Â $
Madal
73,36Â $
Turu kapit.
30,88Â mld
Keskm. maht
2,15Â mln
Maht
528,70Â tuh
52 näd kõrgeim
87,64Â $
52 näd madalaim
61,84Â $
Beeta
0,87
Käibivad aktsiad
483,40Â mln
Töötajate arv
25Â tuh
Ava
73,40Â $
Kõrge
74,26Â $
Madal
73,36Â $
Turu kapit.
30,88Â mld
Keskm. maht
2,15Â mln
Maht
528,70Â tuh
52 näd kõrgeim
87,64Â $
52 näd madalaim
61,84Â $
Beeta
0,87
Käibivad aktsiad
483,40Â mln
Töötajate arv
25Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
BigGo Finance
·
30 minuti eest
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
Benzinga
·
34 minuti eest
S&P 500 Down 1%; Disney Posts Upbeat Earnings
Barron's
·
37 minuti eest
Bear Market Watch: What the Charts Say About the S&P 500
Traders Union
·
30 minuti eest
S&P 500 market cap falls $3 trillion over past week, Peter Tuchman notes
Profiil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Teave üksuse Alcon AG kohta
TegevjuhtDavid J. Endicott
Töötajad25 tuh
Asutatud1945
PeakontoridGenf, Genf, Å veits
SektorHealth Care
Valdkond-
Veebisaitalcon.com